Sandoz Files Lawsuit Against FDA to Force Decision on Omnitrope

Drug Industry Daily
KEYWORDS biotech / courts / FDA
A A

Sandoz has filed a lawsuit against the FDA accusing the agency of unlawfully delaying a decision on the firm’s application to market generic human growth hormone — a move that ramps up pressure on the FDA to issue guidelines for follow-on biologics.

To View This Article:

Login

Subscribe To Drug Industry Daily